BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 113016)

  • 1. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
    DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
    Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity studies on lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
    Chou BJ; Mir GN; Brown WR; Rapp WR; Yelnosky J
    Arzneimittelforschung; 1978; 28(8a):1471-6. PubMed ID: 113015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
    DeLong AF; Smyth RD; Polk A; Nayak RK; Martin G; Douglas GH; Reavey-Cantiwell NH
    Drug Metab Dispos; 1977; 5(2):122-31. PubMed ID: 15804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action studies of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
    Mir GN; Sperow JW; Krebs JB; Eash JR; Rowles GS; Yelnosky J
    Arzneimittelforschung; 1978; 28(8a):1454-61. PubMed ID: 89850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide.
    Mir GN; Alioto RL; Sperow JW; Eash JR; Krebs JB; Yelnosky J
    Arzneimittelforschung; 1978; 28(8a):1448-54. PubMed ID: 582536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
    Mir GN; Sperow JW; Riley RL; Alioto RL; Nuss GW; Chou BJ; Yelnosky J
    Arzneimittelforschung; 1978; 28(8a):1466-70. PubMed ID: 582538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
    Bechtel WD; Mierau J; Richter I; Stiasni M
    Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent on the cardiovascular and central nervous systems.
    Riley RL; Mir GN; Rowles GS; Sperow JW; Alioto RL; Yelnosky J
    Arzneimittelforschung; 1978; 28(8a):1461-6. PubMed ID: 582537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative physiological disposition of ellipticine in several animal species after intravenous administration.
    Chadwick M; Silveira DM; Platz BB; Hayes D
    Drug Metab Dispos; 1978; 6(5):528-41. PubMed ID: 30602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)- 1H-indole-3-methanol (59-801), a hypoglycaemic agent in rats, dogs and monkeys.
    Tse FL; Orwig B; Jaffe JM
    Xenobiotica; 1987 Jun; 17(6):741-9. PubMed ID: 3630208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical-physical profile of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
    Zalipsky JJ; Won CM; Patel DM
    Arzneimittelforschung; 1978; 28(8a):1441-7. PubMed ID: 582535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.
    Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H
    Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.